Skip to content

Genetic Small Vessel Diseases (SVDs) Registry

Genetic Small Vessel Diseases (SVDs) Registry - GenSVDs-Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034054
Enrollment
200
Registered
2024-04-16
Start date
2024-04-10
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genetic hereditary small vessel diseases such as CADASIL (Cerebral Autosomal Dominant Arteriopathy with subcortical Infarcts and Leukoencephalopathy)

Interventions

Group 1: Previous course of disease in patients with hereditary small vessel diseases (at the time of the interview
one-time survey)

Sponsors

LMU Klinikum, Institut für Schlaganfall- und Demenzforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • A diagnosis of hereditary cSVD -CADASIL: Diagnosis is made by molecular genetic testing of the NOTCH3 gene or by detection of granular osmiophilic material (GOM) in ultrastructural electron microscopy analysis of a skin biopsy. -CADASIL-like diseases: Diagnosis is made by molecular genetics, e.g. CADASIL type 2 with autosomal dominant inheritance of mutations in the HTRA1 gene or CADASIL like-diseases (mutations in the TREX1 gene) -CARASIL: Diagnosis is made by molecular genetic testing for biallelic mutations in the HTRA1 gene. • Ability to provide written informed consent or the presence of a legal guardian who can consent to inclusion in the study.

Exclusion criteria

Exclusion criteria: • Inclusion criteria are not met. • Absence of the ability to provide written informed consent or the lack of a legal guardian who can consent to inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Aim: to establish a comprehensive registry by systematically collecting and analyzing data (e.g., mutation, clinical manifestation, medication) from adult patients with a hereditary form of cerebral small vessel diseases in a single in-person or telephone visit

Secondary

MeasureTime frame
(1) impact of hereditary SVD on patients' daily activities and independence, understanding the extent of functional impairment using the modified Rankin Scale (mRS), (2) cognitive function by employing the Montreal Cognitive Assessment (MoCA) test, (3) psychological impact of hereditary SVDs; this involves assessing mood and depression (utilizing tools like CES-D) (4) social and lifestyle factors that may independently or interactively influence the course of hereditary SVD

Countries

Germany

Contacts

Public ContactAnna Kopczak

LMU Klinikum, Institut für Schlaganfall- und Demenzforschung

cadasil@med.uni-muenchen.de+4989440046167

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026